ALPS Medical Breakthroughs ETF (NYSEARCA:SBIO – Get Free Report) saw a significant growth in short interest during the month of August. As of August 14th, there was short interest totaling 78,401 shares, a growth of 74.3% from the July 30th total of 44,970 shares. Currently, 2.5% of the company’s shares are short sold. Based on an average daily volume of 37,830 shares, the days-to-cover ratio is currently 2.1 days.
Institutional Trading of ALPS Medical Breakthroughs ETF
Several large investors have recently added to or reduced their stakes in SBIO. Steward Partners Investment Advisory LLC bought a new position in ALPS Medical Breakthroughs ETF in the fourth quarter worth about $26,000. Comerica Bank bought a new stake in ALPS Medical Breakthroughs ETF in the third quarter worth $27,000. Harbor Investment Advisory LLC bought a new position in ALPS Medical Breakthroughs ETF in the 2nd quarter worth about $29,000. Global Retirement Partners LLC purchased a new stake in shares of ALPS Medical Breakthroughs ETF during the fourth quarter valued at approximately $34,000. Finally, Raymond James Financial Inc. purchased a new stake in ALPS Medical Breakthroughs ETF during the 2nd quarter valued at $82,000.
ALPS Medical Breakthroughs ETF Price Performance
Shares of SBIO stock traded down $1.38 during trading hours on Monday, reaching $65.71. The company’s stock had a trading volume of 14,559 shares, compared to its average volume of 37,750. ALPS Medical Breakthroughs ETF has a one year low of $34.66 and a one year high of $70.85. The firm’s fifty day simple moving average is $65.70 and its 200 day simple moving average is $57.17.
ALPS Medical Breakthroughs ETF Company Profile
The ALPS Medical Breakthroughs ETF (SBIO) is an exchange-traded fund that is based on the S-Network Medical Breakthroughs index. The fund tracks, a market-cap weighted index comprising US-listed biotech companies with one or more drugs currently in either Phase II or Phase III FDA clinical trials. SBIO was launched on Dec 31, 2014 and is managed by ALPS.
Featured Stories
- Five stocks we like better than ALPS Medical Breakthroughs ETF
- Don’t Miss These 3 Companies Delivering Strong Guidance Updates
- Insider Confidence Is Building in These 3 Very Different Stocks
- The SaaSpocalypse Trade Is Cracking, and These 5 Stocks Are Leading Higher
- Microsoft’s Split Verdict Tests Investing Without a Fed Safety Net
Receive News & Ratings for ALPS Medical Breakthroughs ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ALPS Medical Breakthroughs ETF and related companies with MarketBeat.com's FREE daily email newsletter.
